Safety and clinical activity of MK-3475 as initial therapy in patients with advanced non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Rizvi, N. A.; Garon, E. B.; Patnaik, A.; Gandhi, L.; Leighl, N. B.; Balmanoukian, A. S.; Goldman, J. W.; Eder, J. P.; Johnson, E.; Blumenschein, G. R.; Gubens, M. A.; Papadopoulos, K. P.; Lubiniecki, G. M.; Zhang, J.; Niewood, M.; Emancipator, K.; Dolled-Filhart, M.; Hanson, M. E.; Hui, R. N.
Abstract Title: Safety and clinical activity of MK-3475 as initial therapy in patients with advanced non-small cell lung cancer (NSCLC)
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613204072
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.8007
Notes: Meeting Abstract: 8007 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Naiyer A Rizvi
    166 Rizvi